Kinnate Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KNTE and buy or sell other stocks, options, and ETFs commission-free!

About KNTE

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers. Its mission is to expand the reach of targeted therapeutics by developing products for underserved populations. 

CEO
Nima M. Farzan, MBA
CEONima M. Farzan, MBA
Employees
27
Employees27
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2018
Founded2018
Employees
27
Employees27

KNTE Key Statistics

Market cap
124.88M
Market cap124.88M
Price-Earnings ratio
-1.09
Price-Earnings ratio-1.09
Dividend yield
Dividend yield
Average volume
367.46K
Average volume367.46K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.00
52 Week high$6.00
52 Week low
$1.04
52 Week low$1.04
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.